Stockscreener 앱 받기
31.10
0.39%
0.09
전일 마감가:
$31.01
열려 있는:
$30.81
하루 거래량:
220.07K
Relative Volume:
0.11
시가총액:
$4.95B
수익:
$264.79M
순이익/손실:
$-14.36M
주가수익비율:
-282.73
EPS:
-0.11
순현금흐름:
$-28.11M
1주 성능:
-6.40%
1개월 성능:
-9.03%
6개월 성능:
-6.71%
1년 성능:
-10.80%
1일 변동 폭
$30.76
$31.48
1주일 범위
$29.80
$33.51
52주 변동 폭
$25.28
$46.48
TG테라퓨틱스사 Stock (TGTX) Company Profile
명칭
Tg Therapeutics Inc
전화
(212) 554-4484
주소
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
TGTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
31.17 | 4.92B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.38 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
705.00 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.06 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
894.89 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
375.24 | 41.77B | 4.56B | -176.77M | 225.30M | -1.7177 |
TG테라퓨틱스사 Stock (TGTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-06 | 재개 | H.C. Wainwright | Buy |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2024-10-29 | 개시 | TD Cowen | Buy |
| 2023-08-02 | 업그레이드 | Goldman | Sell → Neutral |
| 2023-06-26 | 재개 | Jefferies | Buy |
| 2022-05-20 | 개시 | BofA Securities | Underperform |
| 2022-02-23 | 재확인 | B. Riley Securities | Buy |
| 2021-11-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-04-20 | 개시 | Goldman | Neutral |
| 2021-04-19 | 재확인 | H.C. Wainwright | Buy |
| 2020-09-01 | 개시 | JP Morgan | Overweight |
| 2020-08-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-05 | 개시 | Evercore ISI | Outperform |
| 2020-01-17 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-27 | 재개 | B. Riley FBR | Buy |
| 2019-02-06 | 재개 | Jefferies | Buy |
| 2018-09-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 재개 | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 재개 | H.C. Wainwright | Buy |
| 2017-04-25 | 개시 | Jefferies | Buy |
| 2017-03-06 | 재확인 | FBR & Co. | Outperform |
| 2016-10-06 | 재개 | Brean Capital | Buy |
| 2016-05-27 | 개시 | SunTrust | Buy |
| 2015-12-01 | 개시 | FBR Capital | Outperform |
| 2015-09-09 | 개시 | Raymond James | Strong Buy |
| 2015-08-12 | 재개 | H.C. Wainwright | Buy |
| 2015-06-19 | 재확인 | Brean Capital | Buy |
| 2014-12-11 | 재확인 | ROTH Capital | Buy |
| 2014-12-10 | 재확인 | ROTH Capital | Buy |
모두보기
TG테라퓨틱스사 주식(TGTX)의 최신 뉴스
Will TG Therapeutics Inc. stock benefit from commodity pricesIPO Watch & Weekly High Return Opportunities - newser.com
TG Therapeutics at TD Cowen Summit: Strategic Insights on Briumvi By Investing.com - Investing.com Australia
Is TG Therapeutics Inc. (NKB2) stock nearing a technical breakout2025 Top Decliners & Weekly Top Gainers Alerts - newser.com
Is now a turning point for TG Therapeutics Inc.Stop Loss & Weekly Top Stock Performers List - newser.com
Will TG Therapeutics Inc. (NKB2) stock benefit from commodity supercycleMarket Trend Review & High Conviction Buy Zone Alerts - newser.com
How TG Therapeutics Inc. (NKB2) stock trades under stagflationWeekly Profit Summary & Verified Entry Point Detection - newser.com
TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit - The Manila Times
TG Therapeutics (NASDAQ: TGTX) fireside chat Nov 12 at 10:00 AM ET; webcast available - Stock Titan
Is TG Therapeutics Inc. stock oversold or undervaluedJobs Report & Weekly Momentum Stock Picks - newser.com
Tools to assess TG Therapeutics Inc.’s risk profileJuly 2025 Action & Smart Swing Trading Techniques - newser.com
How to build a dashboard for TG Therapeutics Inc. stockJuly 2025 Levels & Expert Verified Movement Alerts - newser.com
Is it time to cut losses on TG Therapeutics Inc.July 2025 Catalysts & Entry and Exit Point Strategies - newser.com
Will TG Therapeutics Inc. stock attract ESG investorsTrade Ideas & Fast Moving Trade Plans - newser.com
The Bull Case For TG Therapeutics (TGTX) Could Change Following Raised 2025 Outlook and Surging BRIUMVI Sales - Sahm
How to escape a deep drawdown in TG Therapeutics Inc.July 2025 PostEarnings & Reliable Momentum Entry Alerts - newser.com
(TGTX) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
TG Therapeutics (TGTX): Exploring Valuation After Raised Guidance and Strong Q3 Financial Results - Sahm
TG Therapeutics (TGTX) Earnings Date and Reports 2025 - MarketBeat
Will TG Therapeutics Inc. stock outperform value stocks2025 Major Catalysts & Reliable Entry Point Trade Alerts - newser.com
How TG Therapeutics Inc. stock compares to industry benchmarksWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com
TG Therapeutics (TGTX) Financials 2025Income Statement and Balance Sheet - MarketBeat
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics (TGTX) Stock Price, News & Analysis - MarketBeat
Highly Watched TG Therapeutics Smashes Profit Views — But There's A Caveat - MSN
Analyzing recovery setups for TG Therapeutics Inc. investorsRate Hike & Low Drawdown Investment Strategies - newser.com
What Wall Street predicts for TG Therapeutics Inc. stock priceTrade Analysis Report & Safe Capital Growth Trade Ideas - Fundação Cultural do Pará
What dividend safety score for TG Therapeutics Inc. stockBond Market & Long Hold Capital Preservation Tips - newser.com
Decoding TG Therapeutics Inc (TGTX): A Strategic SWOT Insight - GuruFocus
Building trade automation scripts for TG Therapeutics Inc.Trade Performance Summary & Low Volatility Stock Suggestions - newser.com
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo! Finance UK
TGTX's Q3 Earnings & Revenues Trump Estimates, 2025 View Raised - MSN
Can TG Therapeutics Inc. stock resist market sell offsJuly 2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
What technical charts say about TG Therapeutics Inc. stockJuly 2025 Rallies & Weekly High Momentum Picks - fcp.pa.gov.br
Is TG Therapeutics Inc. stock gaining market shareNew Guidance & High Accuracy Trade Signal Alerts - newser.com
Why TG Therapeutics (TGTX) is a Top Growth Stock for the Long-Term - sharewise.com
TG Therapeutics Earns Membership In 95-Plus Composite Rating Club - MSN
TG테라퓨틱스사 (TGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.16%
0.33%
자본화:
|
볼륨(24시간):